DOI: 10.1001/jamanetworkopen.2026.31556 ISSN: 2574-3805
Cost and Coverage of Originator and Biosimilar Ustekinumab Products in Medicare Part D
Grace Castle, Michael A. Carrier, Rachel E. Sachs, Nancy L. Keating, Haiden A. Huskamp, Stacie B. DusetzinaThis cross-sectional study investigates the cost and coverage of ustekinumab originator Stelara and biosimilar products in 2026 for Medicare Part D.